Clinical Trial Update: HER-2 Protein Vaccine in Treating Women With Breast Cancer [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 trial evaluating a HER-2 protein vaccine in women with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HER-2 Protein Vaccine (HER-2 protein vaccine)

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED